Fresenius Medical Care AG
FMCQF
$47.20
-$1.18-2.43%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 20.91B | 20.86B | 21.00B | 21.12B | 21.04B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 20.91B | 20.86B | 21.00B | 21.12B | 21.04B |
Cost of Revenue | 15.77B | 15.62B | 15.68B | 15.76B | 15.71B |
Gross Profit | 5.14B | 5.24B | 5.32B | 5.37B | 5.33B |
SG&A Expenses | 3.40B | 3.41B | 3.45B | 3.46B | 3.46B |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -118.23M | -149.81M | -79.96M | -45.68M | -28.64M |
Total Operating Expenses | 19.25B | 19.10B | 19.28B | 19.41B | 19.39B |
Operating Income | 1.67B | 1.76B | 1.72B | 1.71B | 1.65B |
Income Before Tax | 1.15B | 1.32B | 1.16B | 1.10B | 1.12B |
Income Tax Expenses | 342.60M | 370.66M | 338.81M | 320.56M | 325.40M |
Earnings from Continuing Operations | 803.38 | 953.71 | 823.55 | 776.95 | 792.06 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -219.53M | -238.87M | -251.09M | -253.01M | -252.53M |
Net Income | 583.85M | 714.85M | 572.46M | 523.94M | 539.52M |
EBIT | 1.67B | 1.76B | 1.72B | 1.71B | 1.65B |
EBITDA | 3.10B | 3.22B | 3.20B | 3.32B | 3.17B |
EPS Basic | 1.99 | 2.44 | 1.95 | 1.79 | 1.84 |
Normalized Basic EPS | 2.28 | 2.36 | 2.21 | 2.20 | 2.07 |
EPS Diluted | 1.98 | 2.43 | 1.95 | 1.78 | 1.83 |
Normalized Diluted EPS | 2.28 | 2.36 | 2.21 | 2.20 | 2.07 |
Average Basic Shares Outstanding | 1.17B | 1.17B | 1.17B | 1.17B | 1.17B |
Average Diluted Shares Outstanding | 1.17B | 1.17B | 1.17B | 1.17B | 1.17B |
Dividend Per Share | 1.54 | 1.28 | 1.28 | 1.28 | 1.28 |
Payout Ratio | 64.37% | 52.57% | 65.65% | 68.27% | 66.30% |